U.S. markets open in 8 hours 29 minutes
S&P Futures
3,408.00-24.50(-0.71%)Dow Futures
27,945.00-189.00(-0.67%)Nasdaq Futures
11,612.50-78.75(-0.67%)
Abbott Laboratories (ABT)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
105.93-2.43 (-2.24%)
At close: 4:02PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 108.36 |
| Open | 108.01 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1300 |
| Day's Range | 104.84 - 109.00 |
| 52 Week Range | 61.61 - 114.20 |
| Volume | 5,594,360 |
| Avg. Volume | 5,153,895 |
| Market Cap | 187.552B |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | 61.20 |
| EPS (TTM) | 1.73 |
| Earnings Date | Jan 20, 2021 - Jan 25, 2021 |
| Forward Dividend & Yield | 1.44 (1.33%) |
| Ex-Dividend Date | Oct 14, 2020 |
| 1y Target Est | 116.47 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-6% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Editor's PickYahoo Finance Video
Verizon, Biogen, Abbott earnings breakdown, here's what you need to know
Yahoo Finance's Emily McCormick joins The First Trade with Alexis Christoforous and Brian Sozzi to discuss recent earnings reports from Verizon, Abbott and Biogen.
- Investor's Business Daily
Abbott Laboratories Earnings, Outlook Top Expectations
Abbott Laboratories on Wednesday posted third-quarter earnings and revenue that exceeded Wall Street expectations, as did its earnings guidance for the year, but shares reversed lower.
- Motley Fool
Here's What to Really Like About Abbott Labs' Q3 Results
It's been a banner year so far for Abbott Laboratories (NYSE: ABT). There were plenty of things to like with Abbott's Q3 update. In the same period of 2019, Abbott recorded GAAP earnings of $960 million, or $0.53 per share.
© 2020 Verizon Media. All rights reserved.
